Redfield Robert bought TRAW

October 12, 2025 · Form 4 insider transaction

Redfield Robert bought 32,406 shares of Traws Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
32,406
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (right to purchase)
Transaction codeA: Grant or award
Transaction dateOctober 12, 2025
Filing dateOctober 15, 2025
Shares owned after32,406
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The options vest 100% on the first anniversary of the grant date.

View the original Form 4 on SEC EDGAR